Work

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The World Journal of Biological Psychiatry

DOI: 10.3109/15622975.2011.600333

Authors: Miguel Casas, Michael Rösler, J. J. Sandra Kooij, Ylva Ginsberg, Josep Antoni Ramos-Quiroga, Steffen Heger, Joris Berwaerts, Joachim Dejonckheere, Erik van der Vorst, Barbara Schäuble

Institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Universitätsklinikum des Saarlandes, Saarland University, Karolinska Institutet, Centro de Investigación Biomédica en Red de Salud Mental, Janssen (Belgium), Janssen (Germany)

Language: English

Topic: Attention Deficit Hyperactivity Disorder

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Fundación Alicia Koplowitz, Johnson and Johnson, Cilag

OpenAlex ID: W2074299827

FWCI: 1.884

Cites: 29

Cited by: 40

Related to: 10